Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/009420 stock hub

KRX/009420 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KRX/009420is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.2T
Korea Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
KRX/009420
In the news

Latest news · KRX/009420

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E490.3
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-3.4
P25 -17.1P50 0.7P75 8.5
ROIC-1
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KRX/009420 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
203
Groups with data
11
Currency
KRW
Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
304
Enterprise value
KRW 2.2T
Exchange
Korea Stock Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7009420001
Last refreshed
2026-05-10
Market cap
KRW 2.2T
Price
KRW 44,050
Price currency
KRW
Rev Per Employee
510,475,408.22x
Sector
Healthcare
Sic
2834
Symbol
krx/009420
Website
https://www.hanall.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-0.25%
EV Earnings
-403.67x
EV/FCF
-682.43x
EV/Sales
14.46x
FCF yield
-0.15%
Forward P/E
490.28x
P/B ratio
13.84x
P/S ratio
14.41x
PE Ratio10 Y
410.56x
PE Ratio5 Y
599.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
-1.04%
EBITDA Margin
1.26%
Gross margin
52.05%
Gross Profit
KRW 80.8B
Gross Profit Growth
10.34%
Gross Profit Growth Q
-1.82%
Gross Profit Growth3 Y
9.29%
Gross Profit Growth5 Y
9.82%
Net Income
KRW -5.6B
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-3.98%
Profit Margin
-3.58%
Profit Per Employee
KRW -18.3M
ROA
-0.46
Roa5y
0.71
ROCE
-0.89
ROE
-3.37
Roe5y
0.58
ROIC
-1.02
Roic5y
2.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
10.73%
Cagr15y
11.4%
Cagr1y
65.35%
Cagr20y
17.6%
Cagr3y
25%
Cagr5y
13.88%
Div CAGR10
-6.7%
Div CAGR3
-26.32%
Div CAGR5
-27.52%
EPS Growth Quarters
1
EPS Growth Years
0
Revenue Growth
11.69x
Revenue Growth Q
3.11x
Revenue Growth Quarters
7x
Revenue Growth Years
5x
Revenue Growth3 Y
12.16x
Revenue Growth5 Y
11.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
KRW 0.71
Assets
KRW 225.2B
Cash
KRW 24.7B
Current Assets
KRW 84.9B
Current Liabilities
KRW 44.5B
Debt
KRW 31.9B
Debt EBITDA
KRW 16.37
Debt Equity
KRW 0.2
Debt FCF
KRW -9.71
Equity
KRW 161.7B
Interest Coverage
-11.31
Liabilities
KRW 63.5B
Long Term Assets
KRW 140.3B
Long Term Liabilities
KRW 19.1B
Net Cash
KRW -7.2B
Net Cash By Market Cap
KRW -0.32
Net Debt EBITDA
KRW 3.68
Net Debt Equity
KRW 0.04
Tangible Book Value
KRW 157.2B
Tangible Book Value Per Share
KRW 3,096
WACC
7.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.91
Inventory Turnover
1.96
Net Working Capital
KRW 32B
Quick ratio
0.99
Working Capital
KRW 40.4B
Working Capital Turnover
KRW 3.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.13%
Dividend per share
KRW 0
Last Dividend
KRW 10

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
177.04%
1Y total return
65.29%
200-day SMA
42,915.3
3Y total return
95.34%
50-day SMA
52,523
50-day SMA vs 200-day SMA
50over200
5Y total return
91.52%
All Time High
66,600
All Time High Change
-33.86%
All Time High Date
2026-03-26
All Time Low
234.9
All Time Low Change
18,651.7%
All Time Low Date
1997-12-29
ATR
2,799.9
Beta
0.65
Beta1y
0.75
Beta2y
0.88
Ch YTD
0.69
High
45,500
High52
66,600
High52 Date
2026-03-26
High52ch
-33.86%
Low
43,900
Low52
24,000
Low52 Date
2025-06-30
Low52ch
83.54%
Ma50ch
-16.13%
Price vs 200-day SMA
2.64%
RSI
36.25
RSI Monthly
54.04
RSI Weekly
45.94
Sharpe ratio
0.93x
Sortino ratio
1.58
Total Return
-0.13%
Tr YTD
0.69
Tr15y
405.16%
Tr1m
-4.24%
Tr1w
-4.86%
Tr3m
-9.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -1.6B
Operating margin
-1.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
34,440,617%
Net Borrowing
29,900,142,890
Shares Insiders
0.44%
Shares Institutions
14.47%
Shares Out
50,780,857
Shares Qo Q
-1.06%
Shares Yo Y
0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
KRW -3.6B
Average Volume
330,050.6x
Bv Per Share
3,183.9
CAPEX
KRW -948M
Ch10y
177
Ch15y
405.2
Ch1m
-4.24
Ch1w
-4.86
Ch1y
65.29
Ch20y
2,320.3
Ch3m
-9.73
Ch3y
95.34
Ch5y
91.52
Ch6m
-4.86
Change
-0.68%
Change From Open
-2
Close
44,350
Days Gap
1.35
Depreciation Amortization
3,560,964,000
Dollar Volume
11,974,419,850
Earnings Date
2026-05-13
EBIT
KRW -1.6B
EBITDA
KRW 1.9B
EPS
KRW -109
F Score
2
FCF
KRW -3.3B
FCF EV Yield
-0.15x
FCF Per Share
KRW -64.76
Financing CF
29,565,917,660
Fiscal Year End
December
Founded
1,973
Income Tax
KRW -620.7M
Investing CF
-18,831,502,660
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Last Split Date
2006-04-28
Last Split Type
Forward
Ma150
47,338
Ma150ch
-6.95%
Ma20
48,102.5
Ma20ch
-8.42%
Net CF
8,356,859,250
Next Earnings Date
2026-05-13
Open
44,950
Position In Range
9.38
Ppne
17,092,087,250
Price Date
2026-05-08
Price EBITDA
KRW 1,147
Ptbv Ratio
14.23
Relative Volume
0.82x
Revenue
155,184,524,100x
SBC By Revenue
0.22x
Share Based Comp
340,683,000
Tax By Revenue
-0.4x
Tr20y
2,459.73%
Tr6m
-4.86%
Volume
271,837
Z Score
17.12
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KRX/009420 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/009420 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+65.3%
S&P 500 1Y: n/a
3Y total return
+95.3%
S&P 500 3Y: n/a
5Y total return
+91.5%
S&P 500 5Y: n/a
10Y total return
+177.0%
S&P 500 10Y: n/a
Ownership

Who owns KRX/009420?

Insider, institutional, and short-interest positioning.

Institutional ownership
+14.5%
Share of float held by funds and institutions
Insider ownership
+0.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

KRX/009420 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.3
Neutral momentum band
Price vs 200-day MA
+2.6%
50/200-day relationship not available
Beta (5Y)
0.65
Less volatile than the market
Sharpe ratio
0.93
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KRX/009420

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/009420 stock rating?

krx/009420 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/009420 analysis?

The full report lives at /stocks/krx/009420/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/009420?

The latest report frames krx/009420 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/009420 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.